Chemotherapy Induced Peripheral Neuropathy Drug Pipeline Research 2024: Therapeutics Assessment by Product Type, Stage, Route of Administration, and Molecule Type
June 26, 2024 09:26 ET
|
Research and Markets
Dublin, June 26, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.An insightful report...
Epilepsy Therapeutics Market Poised for Growth; Innovations and Advances to Fuel Expansion Through 2034
May 29, 2024 04:19 ET
|
Research and Markets
Dublin, May 29, 2024 (GLOBE NEWSWIRE) -- The "Epilepsy Therapeutics Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global epilepsy therapeutics market is...
Global Peripheral Neuropathy Market Report 2022: Strategic Insight and Analysis of Key Drivers, Market Factors & Players
October 25, 2022 06:33 ET
|
Research and Markets
Dublin, Oct. 25, 2022 (GLOBE NEWSWIRE) -- The "Peripheral Neuropathy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
Peripheral Neuropathy Treatment Market Report 2022: Featuring Abbott, Eli Lilly, Pfizer, NeuroBo, Teva & Others
September 23, 2022 06:53 ET
|
Research and Markets
Dublin, Sept. 23, 2022 (GLOBE NEWSWIRE) -- The "Peripheral Neuropathy Treatment Market, by Indication, by Treatment and Non-Pharmacological Therapies, by End-user, and by Region - Size, Share,...
Epilepsy - Worldwide Market and Epidemiology Insights & Forecasts to 2030
January 22, 2021 04:08 ET
|
Research and Markets
Dublin, Jan. 22, 2021 (GLOBE NEWSWIRE) -- The "Epilepsy - Market Insight, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering. This report...